picks — 2026-05-26

Picks (written 2026-05-26)

by xavier.grehant

Marked Improvement of Sialorrhea with Safinamide in Parkinson's Disease: A Case Series Movement Disorders (Wiley) · 2026-05-21

Approved PD drug safinamide markedly reduces drooling; ask your neurologist now.
Young Plasma Infusions Significantly Improve Clinical Symptoms and UPDRS Scores in Patients with Parkinson's Disease medRxiv — Neurology preprints · 2026-05-22

Preliminary human trial: young plasma infusions improved motor UPDRS scores.
Locked to the match: subthalamic engagement in sport match viewing medRxiv — Neurology preprints · 2026-05-22

Adaptive DBS tracks neural state during passive activities, not only movement.
Co‐ and Multi‐Pathologies in Parkinson's Disease: An International Parkinson and Movement Disorder Society Scientific Issues Committee Review summary Movement Disorders (Wiley) · 2026-05-22

Expert review: co-pathologies in most PD patients reshape symptoms and prognosis.
PD GENEration: An International Parkinson's Disease Genetic Research Study summary medRxiv — Neurology preprints · 2026-05-22

PD GENEration expands free genetic testing and counseling access internationally.

Traitement de Parkinson : « Les ultrasons vont certainement être une révolution » - L’Écho Républicain Google Actualités — « maladie de Parkinson » · 2026-05-24

Neurologist explains why focused ultrasound may be next major PD treatment.
Parkinson : quels antidouleurs sont efficaces ? - Yahoo Life France Google Actualités — « maladie de Parkinson » · 2026-05-23

Practical guide to which analgesics are effective for PD-specific pain.
La acción terapéutica de la ayahuasca en párkinson es independiente de sus efectos alucinógenos - Salud a Diario Google News — «párkinson» (es) · 2026-05-23

Ayahuasca's PD benefits shown separable from hallucinogenic effects, opening new path.